West Virginia School of Osteopathic Medicine
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, West Virginia School of Osteopathic Medicine sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
West Virginia School of Osteopathic Medicine: 6 sponsored US clinical trials, 1 recruiting.
West Virginia School of Osteopathic Medicine sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Hyperlipidemias, with 1 trials.
Upper-quartile sponsor footprint
West Virginia School of Osteopathic Medicine sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
NCT06049420
Recovery Works - Facilitating Sustainable Recovery Through Workforce
NCT07216612
Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children
NCT01465789
Biomarkers of Metabolic Syndrome and Prediabetes
NCT01086137
Biomarkers of the Response to Osteopathic Manipulation
NCT00958646
Osteopathic Otitis Media Research Study
NCT00520039
Therapeutic Areas
What is open in the West Virginia School of Osteopathic Medicine pipeline
1 recruiting of 6 indexed (17% open); 3 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Hyperlipidemias (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
West Virginia School of Osteopathic Medicine: open-pipeline peers nationwide
Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
West Virginia School of Osteopathic Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this West Virginia School of Osteopathic Medicine page
6 registered trials is a research-attention snapshot, not an endorsement of West Virginia School of Osteopathic Medicine or any single study.
- 1 of West Virginia School of Osteopathic Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hyperlipidemias is the condition West Virginia School of Osteopathic Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hyperlipidemias trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
West Virginia School of Osteopathic Medicine pipeline card: 6 registered trials from official public datasets.Report a data error.